Savolitinib is an experimental small molecule inhibitor of
c-Met. It is being investigated for the treatment of cancer by
AstraZeneca. It is in phase II clinical trials for
adenocarcinoma
Adenocarcinoma (; plural adenocarcinomas or adenocarcinomata ) (AC) is a type of cancerous tumor that can occur in several parts of the body. It is defined as neoplasia of epithelial tissue that has glandular origin, glandular characteristics, or ...
,
non-small cell lung cancer, and
renal cell carcinoma.
It has been given conditional approval for these indication in China.
References
External links
*
{{Portal bar , Medicine
AstraZeneca brands
Tyrosine kinase inhibitors
Pyrazoles
Imidazopyridines
Experimental cancer drugs